Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Clinical Trial Evidence and Weight Loss Outcomes A Phase 2 RCT (NEJM 2023) reported approximately 24% mean body weight reduction at 48 weeks with the 12 mg dose
Tyrosinase is an enzyme that catalyzes the biosynthesis of melanin which is a culprit for skin darkening
Polypharmacology is the basis for drug repurposing: this principle asserts that a drug with multiple targets can have multiple mechanisms of action (Nowak-Sliwinska et al., 2019)
Development of Multi-Indication Products Targeting Broader Metabolic Disorders There is growing opportunity to position GLP-1 therapies as multifunctional agents beyond glycemic control
US$ 22.66
US$ 20.74
US$ 29.38
US$ 28.93
US$ 25.18
US$ 21.65
